Concepedia

Maria Ferrantini

MF

Statistics

Publications

34

Citations

2.2K

H-Index

24

Active since

1984

Affiliations

Istituto Superiore di Sanità(Current)

University of Chieti-Pescara

Institut des Sciences Biologiques

Fondazione IRCCS Istituto Nazionale dei Tumori

Inserm

Maria Ferrantini is an author at Istituto Superiore di Sanità specializing in immunology, oncology, and life sciences.

ORCID

Publications per year

1984–2018

34

Publications

34

Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection

Nathalie Chaput, Noël E.C. Schartz, Fabrice André et al. · The Journal of Immunology · 2004 · 266 citations · Full text

, , +17

IFN-α2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells

Elisabetta Padovan, Giulio C. Spagnoli, Maria Ferrantini et al. · Journal of Leukocyte Biology · 2002 · 231 citations

, , +17

IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells.

Elisabetta Padovan, Giulio C. Spagnoli, Maria Ferrantini et al. · PubMed · 2002 · 216 citations

, , +17

IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing

Francesca Spadaro, Caterina Lapenta, Simona Donati et al. · Blood · 2011 · 145 citations · Full text

, , +17

Inhibition of Angiogenesis and Vascular Tumor Growth by Interferon-Producing Cells

Adriana Albini, Chiara Marchisone, Federica Grosso et al. · American Journal Of Pathology · 2000 · 127 citations · Full text

, , +14

1–5 of 34